|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||15.67 / 24.79|
Jefferies upped its price target to $24 on Boston Scientific (BSX) stock this morning.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCC, CYS, DISH, ESRT, FCFS, FSI, GIMO, INVA, KSU, NATI, ORC, RMCF, TREE, WLDN, WMGI, WRE, ZION Downgrades: ACIW, ACOR, BSX, DLR, FI, HTH, IP, OVBC, SBBX Initiations: GNRT, MB, PUB Read on to get TheStreet Quant Ratings' detailed report:
Boston Scientific (BSX) stock is advancing this morning after the company posted better-than-expected fiscal 2016 second quarter revenue before today's opening bell.
Trade-Ideas LLC identified Boston Scientific (BSX) as an unusual social activity candidate
Trade-Ideas LLC identified Boston Scientific (BSX) as a post-market leader candidate
TheStreet highlights 3 stocks pushing the health care sector lower today.
Addition of Leading Radiofrequency Ablation Company Expands Therapeutic Options for Patients with Chronic Pain
TheStreet highlights 3 stocks pushing the health services industry lower today.
Can medical technology stocks continue their momentum higher in the second half of the year? Investors say yes, but technical analysis says not necessarily.
Listen to what the companies are actually telling you. Then assess what that might mean for the future, Cramer says.
Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.
Studies show that treatment is less costly and has lower hospital re-admissions
There is so much buying power in so many new areas.
Wall Street made its best effort to extend a three-day winning streak into a fourth session on Thursday but last-minute moves toward the flatline weren't enough.
Stocks extend their decline by early afternoon Thursday as investors engage in profit-taking after three days of gains.
Boston Scientific (BSX) stock is climbing this afternoon after the company announced a restructuring program.
Stocks extended their decline on Thursday as investors engaged in profit-taking after three days of gains.
U.S. indices indicted a lower opening while Envision Healthcare talks merger and Boston Sciefitic announces global restructuring.
Stock futures point to a pullback on Wall Street Thursday as crude oil falls below $51 a barrel.
U.S. stock futures are trading lower Thursday and European shares fall back as mining stocks slip.
Accelerates momentum to bring differentiated value to patients and health care systems
Cramer says CVS is way too cheap and he's taking Pepsico over Coca-Cola.
Any company that knows its customers will continue to be rewarded in this market, Cramer says.
Apple, Microsoft and three others are not being rewarded for their success and frugality, Cramer says.